483 Response Fougera Pharmaceuticals Jun 2000

Peter Abel FDA, Kim Thomas Cruse FDA$119.00 - Available Now

FDA investigators audited the Fougera Pharmaceuticals - Melville, NY, United States facility and issued inspectional observation (via FDA 483) on 29 Jun 2000.

Product details

  • Category:
  • Inspection end: 29 Jun 2000
  • Location: Melville, United States
  • FEI: 2432435
Add To Cart